Sage Journals: Discover world-class research

Abstract

Introduction and goal:

Currently, 1–2% of the population in developed countries are under treatment with oral anticoagulants. An appropriate strategy to deal with this increase in demand of treatment with oral anticoagulants and to manage the costs is the transfer of part or all of the responsibility for managing treatment to the patients. The use of information technology, particularly electronic health software, can be an appropriate method to improve the quality of self-management of treatment with these drugs. Therefore, this systematic review investigated studies that discuss the characteristics of electronic health software in self-management of oral anticoagulation therapy.

Method:

A systematic review based on PRISMA protocol was conducted. In this study, articles were investigated that were in English. Articles existing in Cochrane, EMBASE and PubMed databases were searched up to 14 May 2017. Then, articles searched through Google Scholar were added to this study.

Findings:

The common characteristics used in most software included ‘encryption in exchanging information’, having an ‘instruction module’ and ‘being Android-based’. In terms of functionality, ‘communication between the patient and healthcare team’ existed in most of the software.

Conclusion:

The results of the study showed that the accuracy of administration of the dose of the drug using computer to reach a target international normalized ratio level was not less than those administered with experienced medical staff. In addition, the results indicated that important characteristics of the software include encryption in exchanging information, instruction module and Android-based instruction module. The most important characteristic was the interaction between the patient and the healthcare team.

Keywords

Vitamin K antagonists oral anticoagulation therapy self-management electronic health software

Get full access to this article

View all access options for this article.

References

Christensen

TD.

Self-management of oral anticoagulation therapy – methodological and clinical aspects. Dan Med Bull 2011; 58: B4284.

Hirsh

Warkentin

Shaughnessy

et al . HEparin and low-molecular-weight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119(1 Suppl.): 64S-94S.

Koopman

MMW

Prandoni

Piovella

et al . Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334: 682-687.

Levine

Gent

Hirsh

et al . A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677-681.

Turpie

AGG

Levine

Hirsh

et al . A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986; 315: 925-929.

Hampers

Blaufox

Merrill

JP.

Anticoagulation rebound after hemodialysis. N Engl J Med 1966; 275: 776-778.

Zusman

Rubin

Cato

et al . Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med 1981; 304: 934-939.

Bereznicki

Jackson

Peterson

GM.

Supervised patient self-testing of warfarin therapy using an online system. J Med Internet Res 2013; 15: e138.

Nutescu

Bathija

Sharp

et al . Anticoagulation patient self-monitoring in the United States: Considerations for clinical practice adoption. Pharmacotherapy 2011; 31: 1161-1174.

10.

Christensen

Grove

Nielsen

et al . Self-managed oral anticoagulant therapy: A call for implementation. Expert Rev Cardiovasc Ther 2016; 14: 255-257.

11.

Moll

Waldron

. INR self testing. North Carolina, US: Hemophilia and Thrombosis Center University Of North Carolina, 2014.

12.

Connock

Stevens

Fry-Smith

et al . Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: A systematic review and economic modelling. Health Technol Assess 2007; 11: 86.

13.

Tideman

Tirimacco

St John

et al . How to manage warfarin therapy. Aust Prescr 2015; 38: 44.

14.

Jowett

Bryan

Poller

et al . The cost-effectiveness of computer-assisted anticoagulant dosage: Results from the European Action on Anticoagulation (EAA) multicentre study. J Thromb Haemost 2009; 7: 1482-1490.

15.

Poller

Keown

Ibrahim

et al . A multicentre randomised clinical endpoint study of parma 5 computer-assisted oral anticoagulant dosage. Br J Haematol 2008; 143: 274-283.

16.

Poller

Shiach

MacCallum

et al . Multicentre randomised study of computerised anticoagulant dosage. Lancet 1998; 352: 1505-1509.

17.

Lee

J-A

Nguyen

Berg

et al . Attitudes and preferences on the use of mobile health technology and health games for self-management: Interviews with older adults on anticoagulation therapy. JMIR Mhealth Uhealth 2014; 2: e32.

18.

Lee

J-A

Evangelista

Moore

et al . Feasibility study of a mobile health intervention for older adults on oral anticoagulation therapy. Gerontol Geriatr Med 2016; 2: 2333721416672970.

19.

Ansell

Jacobson

Levy

et al . Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. Int J Cardiol 2005; 99: 37-45.

20.

Stephan

Almeida

Guimaraes

et al . Processes and recommendations for creating mHealth apps for low-income populations. JMIR Mhealth Uhealth 2017; 5: e41.

21.

Wright

Duffull

SB.

A Bayesian dose-individualization method for warfarin. Clin Pharmacokinet 2013; 52: 59-68.

22.

Jones

Sullivan

Barrett

INRstar: Computerised decision support software for anticoagulation management in primary care. J Innov Health Inform 2005; 13: 215-221.

23.

Kotecha

Chua

Fabritz

et al . European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers. Europace 2017; 20: 225-233.

24.

Finkelstein

Khare

Ansell

Feasibility and patients’ acceptance of home automated telemanagement of oral anticoagulation therapy. AMIA Annu Symp Proc 2003: 2003: 230-234.

25.

Barricelli

Devis

Abdelnour-Nocera

et al . MANTRA: Mobile anticoagulant therapy management. In: Proceedings of the 7th International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth ‘13); 2013 5–8 May, Venice, Italy. Belgium: ICST (Institute for Com-puter Sciences, Social-Informatics and Telecommunications Engineering), Brussels, Belgium; 2013, pp. 278–81.

26.

Manotti

Pattacini

Quintavalla

et al . Computer assisted anticoagulant therapy. Pathophysiol Haemost Thromb 2003; 33: 366-372.

27.

Christensen

Lauterlein

Sørensen

et al . Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemed J Ehealth 2011; 17: 169-176.

28.

Ferrando

Mira

Effective and safe management of oral anticoagulation therapy in patients who use the internet-accessed telecontrol tool SintromacWeb. Interact J Med Res 2015; 4: e10.

29.

Barricelli

Valtolina

Abdelnour-Nocera

. Sociotechnical design of mHealth applications for chronic diseases. In: Workshop on Mobile Healthcare for the Self-Management of Chronic Diseases and the Empowerment of Patients: Proceedings of the 18th international conference on human–computer interaction with mobile devices and services adjunct; 2016, 6–9 September, Florence (Tuscany), Italy. USA: ACM, New York, NY, USA; 2016. pp. 1097–1100.

30.

Guo

Lee

Nguyen

et al . Attitudes and preferences of the use of mobile health technology and health games for self-management in older adults on anticoagulation therapy. JMIR Publications, Toronto, Canada. 2014.

31.

Dimberg

Grzymala-Lubanski

Hägerfelth

et al . Computerised assistance for warfarin dosage – effects on treatment quality. Eur J Intern Med 2012; 23: 742-744.

32.

Gravenhorst

Muaremi

Bardram

et al . Mobile phones as medical devices in mental disorder treatment: An overview. Pers Ubiquitous Comput 2014; 19: 335-353.

33.

Smith

RM.

Collection, interpretation, and delivery of information in mobile health informatics. Irvine: University of California, 2014.

34.

Brian

Ben-Zeev

Mobile health (mHealth) for mental health in Asia: Objectives, strategies, and limitations. Asian J Psychiatry 2014; 10: 96-100.

35.

Fiordelli

Diviani

Schulz

PJ.

Mapping mHealth research: A decade of evolution. J Med Internet Res 2013; 15: e95.

36.

Hamine

Gerth-Guyette

Faulx

et al . Impact of mHealth chronic disease management on treatment adherence and patient outcomes: A systematic review. J Med Internet Res 2015; 17: e52.

37.

Fitzmaurice

Gardiner

Kitchen

et al . An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation. Br J Haematol 2005; 131: 156-165.

38.

Rahmati-Najarkolaei

Ghaffarpasand

Gholami Fesharaki

et al . Nutrition and physical activity educational intervention on CHD risk factors: A systematic review study. Arch Iran Med 2015; 18: 51–57.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.53 MB

Characteristics of software used in self-management of vitamin K antagonist therapy: A systematic review

Abstract

Introduction and goal:

Method:

Findings:

Conclusion:

Keywords

Get full access to this article

References

Supplementary Material